Form 4: Emergent BioSolutions Executive Sells Shares
Insider Transaction Filing
Paul Anthony Williams, SVP of Products Business at Emergent BioSolutions Inc., reported a transaction involving the withholding of shares to cover tax obligations.
Summary
- Paul Anthony Williams, Senior Vice President of Products Business at Emergent BioSolutions Inc., engaged in a transaction on June 8, 2026.
- This transaction involved the withholding of 694 shares of common stock.
- The shares were withheld to cover tax obligations related to the vesting and settlement of restricted stock units.
- Following this transaction, Mr. Williams beneficially owns 162,098 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction for tax settlement and does not provide new financial or strategic information.
Future Outlook
No forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions, often related to routine events like tax payments upon vesting of equity awards, and do not typically indicate significant strategic shifts or financial performance changes.
Key Dates
| Date | Description |
|---|---|
| 06/08/2026 | Transaction date for the withholding of shares. |
| 06/10/2026 | Date of signature for the filing. |
Keywords
Form 4, SEC Filing, Emergent BioSolutions, EBS, Insider Transaction, Stock Withholding, Restricted Stock Units, Tax Payment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.